Business Context and Reporting Period
Company: Nanophase Technologies Corporation (Note: Metadata listed "SOLESENCE, INC." but filing text confirms Nanophase Technologies Corporation, ticker NANX).
Reporting Period: Quarterly period ended March 31, 2010 (Form 10-Q).
Business Overview: Nanophase is a nanomaterials developer and commercial manufacturer producing engineered nanomaterials for sunscreens, personal care, architectural coatings, industrial coatings, and polishing applications. The company operates as a single business segment with all long-lived assets located in the United States.
Key Financial Metrics
| Metric | Q1 2010 | Q1 2009 |
|---|---|---|
| Total Revenue | $2,010,182 | $1,405,158 |
| Gross Profit | $483,085 | $90,234 |
| Gross Margin | 24.0% | 6.4% |
| Net Loss | $(1,145,149) | $(2,108,654) |
| Loss Per Share (Basic/Diluted) | $(0.05) | $(0.10) |
| Cash and Cash Equivalents | $3,108,898 | $489,592 |
| Total Investments | $3,594,106 | $3,594,604 |
| Total Current Assets | $9,929,825 | $10,009,756 |
| Total Current Liabilities | $1,446,300 | $758,711 |
| Net Cash Used in Operating Activities | $(769,755) | $(1,393,561) |
Material Changes vs. Prior Period
- Revenue Growth: Total revenue increased 43% year-over-year, driven primarily by a 49% increase in product revenue ($1.93M vs $1.30M). This was attributed to increased purchases from BASF, the company's largest customer.
- Margin Expansion: Gross profit improved significantly to $483,085 (24% margin) from $90,234 (6% margin) in Q1 2009, despite a 16% increase in cost of revenue. Management attributes this to better absorption of fixed manufacturing costs due to higher volume.
- Expense Increases: Selling, general, and administrative (SG&A) expenses rose 21% to $1.21M, largely due to non-cash equity compensation charges driven by a share price increase and legal fees related to a resolved arbitration with Credit Suisse. R&D expenses increased slightly to $429,263 due to patent application costs.
- Loss Reduction: Net loss decreased by approximately 46% compared to the prior year, excluding a one-time severance charge of $794,069 recorded in Q1 2009.
- Liquidity Position: Cash and cash equivalents increased significantly to $3.11M from $489k in the prior year period. Total liquid assets (cash + investments) stood at approximately $6.7M.
Guidance, Outlook, and Risks
- Outlook: Management expects growth in end-user adoption in 2010 and beyond. Capital spending for the remainder of 2010 is estimated at approximately $290,000, though this could increase based on customer demand.
- Subsequent Event: On March 26, 2010, the company agreed to sell its remaining auction rate securities (ARS) for $4 million to Credit Suisse. The sale closed on April 1, 2010.
- Key Risk - Customer Concentration: Three customers accounted for approximately 85% of total revenue in Q1 2010 (68%, 10%, and 7%).
- Key Risk - Supply Agreement Covenants: The supply agreement with BASF contains financial covenants. If the company's earnings are negative for a 12-month period AND cash/cash equivalents fall below $2.0 million, or if debt is accelerated, BASF may trigger a technology transfer or equipment sale. Management believes current cash levels (~$7M including investments) avoid this trigger for the foreseeable future.
- Tax Position: The company has a net operating loss carryforward of approximately $80 million, subject to expiration and potential limitations due to ownership changes.
Investor Verification Checklist
- Customer Concentration: Verify the stability of the top three customers, particularly BASF, which drives the majority of revenue.
- Covenant Compliance: Monitor cash and cash equivalents to ensure they remain above the $2.0 million threshold required to avoid triggering the BASF supply agreement covenants.
- ARS Sale Proceeds: Confirm the receipt of the $4 million from the auction rate securities sale completed in April 2010.
- Margin Sustainability: Assess whether the improved gross margins are sustainable as fixed costs are absorbed or if they are temporary due to specific product mix.
- Capital Requirements: Evaluate if the projected $290,000 capital spend is sufficient or if unplanned growth will require dilutive financing.